Product Information
Name:Ilginatinib
Brand:Biosynth
Description:Ilginatinib is a cell-factor inhibitor that has been identified as a potential therapeutic agent for the treatment of cancers. Ilginatinib inhibits Jak2V617F, which is an oncogenic mutation in the Jak2 gene. This mutation leads to uncontrolled growth and survival of hematopoietic cells, which are cells that produce blood cells. Ilginatinib has been shown to inhibit colony-stimulating factor (CSF), which is an inflammatory cytokine that can lead to tumor progression. The molecular modeling study indicated that ilginatinib may bind with hydrogen bonds to the active site of Jak2V617F and thereby inhibit its activity. It also prevents activation of jak2 v617f by inhibiting epidermal growth factor receptor, which is a cell surface protein. Ilginatinib also inhibits the synthesis of hematopoietic growth factors such as stem cell factor and erythropoietin, leading to decreased proliferation in these
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:389.43 g/mol
Formula:C21H20FN7
Purity:Min. 95%
Technical inquiry about: Ilginatinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.